Position in GILD
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$919,755
-$102,523 QoQ
Shares Held
7,280
-0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,107
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesley Taft & Associates LLC holds $123,067,788 across 10 Drug Manufacturers - General names. GILD ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
209,735 | $53,266,397 | |
| 2 | LLY |
ELI LILLY & Co
|
20,347 | $24,404,803 | |
| 3 | AZN |
Astrazeneca PLC
|
81,276 | $15,411,554 | |
| 4 | MRK |
Merck & Co., Inc.
|
55,810 | $7,171,585 | |
| 5 | AMGN |
Amgen Inc
|
18,897 | $6,842,981 | |
| 6 | NVS |
Novartis AG
|
32,410 | $5,079,295 | |
| 7 | ABBV |
AbbVie Inc.
|
19,924 | $5,013,674 | |
| 8 | PFE |
Pfizer Inc
|
194,317 | $4,679,152 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $919,755 | 7,280 | Shares | Other | 2026-07-08 | |
| 2026-03-31 | $1,022,278 | 7,335 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $854,393 | 6,961 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $533,355 | 4,805 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $362,988 | 3,274 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $257,715 | 2,300 | Shares | Sole | 2025-04-10 | |
| No filing history on record for this holder in this stock. | ||||||